Use of an Osteoconductive Scaffold in ACL-Reconstruction

NAActive, not recruitingINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

April 29, 2017

Primary Completion Date

January 29, 2024

Study Completion Date

December 29, 2025

Conditions
ACL - Anterior Cruciate Ligament RuptureACLACL Injury
Interventions
DEVICE

Osteoconductive scaffold-hamstring tendon composite repair

The device under study is a composite bone substitute composed of a natural mineral matrix of bovine origin, reinforced with biodegradable synthetic polymers and natural collagen derivatives of bovine origin (smartbone, IBI S.A., Switzerland).

DEVICE

Hamstring tendon-only repair

ACL-reconstruction using hamstring autograft with hybrid fixation in accordance with in-house standard of care.

Trial Locations (1)

8008

Balgrist University Hospital, Zurich

All Listed Sponsors
lead

Sandro Fucentese

OTHER

NCT03462823 - Use of an Osteoconductive Scaffold in ACL-Reconstruction | Biotech Hunter | Biotech Hunter